HBM Healthcare Investments (Cayman) Ltd. - Feb 9, 2023 Form 3 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role
10%+ Owner
Signature
/s/ Jean-Marc LeSieur, Managing Director
Stock symbol
MLYS
Transactions as of
Feb 9, 2023
Transactions value $
$0
Form type
3
Date filed
2/9/2023, 08:04 PM
Previous filing
Nov 12, 2021
Next filing
Feb 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MLYS Series A Preferred Stock Feb 9, 2023 Common Stock 1.94M Direct F1
holding MLYS Series B Preferred Stock Feb 9, 2023 Common Stock 964K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Upon the closing of the Issuer's initial public offering ("IPO"), each share of Series A Preferred Stock beneficially owned by the reporting person will automatically convert, for no additional consideration, into the number of shares of Common Stock reported in Column 3. These shares of Series A Preferred Stock have no expiration date.
F2 Upon the closing of the Issuer's IPO, each share of Series B Preferred Stock beneficially owned by the reporting person will automatically convert, for no additional consideration, into the number of shares of Common Stock reported in Column 3. These shares of Series B Preferred Stock have no expiration date.